Tenders/Pharmaceutical specialty based on immunoglobulins from human plasma for IV administration

Open🇧🇪BelgiumSupplies

Pharmaceutical specialty based on immunoglobulins from human plasma for IV administration

Auto-translated from French

Original title: Spécialité pharmaceutique à base d'immunoglobulines issues du plasma humain à administration IV

Healthcare Public Procurement (HeCaPP)

Published: Oct 14, 2026

Updated: Oct 16, 2026

Source: Belgium e-Procurement

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Belgium, Europe, this opportunity is open to firms and consortiums.

Published through Belgium e-Procurement, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: French

This tender, sourced from Belgium via the belgium_eprocurement platform, concerns a pharmaceutical specialty based on immunoglobulins derived from human plasma for intravenous administration. The contracting authority is seeking a supplier for this critical medical product. Requirements typically include adherence to stringent pharmaceutical regulations, including Good Manufacturing Practice (GMP) and specific national/European health authority approvals. The tender will likely detail specifications regarding the immunoglobulin type, concentration, volume, purity, storage conditions (e.g., cold chain management), and packaging. Bidders must demonstrate the ability to ensure a consistent, safe, and reliable supply of this therapy. This involves providing product licenses, certificates of analysis, and details of their supply chain integrity. The procurement is vital for patient treatment within Belgium's healthcare system, addressing conditions requiring immunoglobulin therapy. Potential suppliers are advised to carefully review the full tender documentation for precise technical requirements, delivery schedules, tender evaluation criteria, and submission procedures.

Data provenance

This notice is sourced from Belgium e-Procurement and was originally published on October 14, 2026. Last refreshed today. Original language: French. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Healthcare Public Procurement (HeCaPP)

Healthcare Public Procurement (HeCaPP) has issued 69 procurement notices on BidsFactory, including 7 currently open and 28 awarded contracts. Activity concentrates in Health & Medical, Industry & Manufacturing, and Information & Communication Technology. All notices are published for Belgium. Notices are distributed via Belgium e-Procurement and TED - Tenders Electronic Daily (EU). Most recent publication: October 14, 2026.

Frequently asked questions about this tender

Who is the contracting authority?

This notice was issued by Healthcare Public Procurement (HeCaPP) in Belgium. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Belgium. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Belgium e-Procurement to access the full notice, required documents, and submission instructions provided by the contracting authority.